AZ960, a Novel Jak2 Inhibitor, Induces Growth Arrest and Apoptosis in Adult T-Cell Leukemia Cells

Jing Yang(Xuzhou Medical College), Akihito Yokoyama(Kōchi University)

Molecular Cancer Therapeutics

December 1, 2010

10.1158/1535-7163.mct-10-0416

Cited by 29

Related Papers

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells

|Leukemia|2008|86

Downregulation of miR‐217 correlates with resistance of ph<sup>+</sup> leukemia cells to <scp>ABL</scp> tyrosine kinase inhibitors

|Cancer Science|2013|60

Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia

|International Journal of Cancer|2011|47

Analysis of Aurora B kinase in non-Hodgkin lymphoma

|Laboratory Investigation|2009|39

Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells <i>via</i> AKT signaling

|International Journal of Cancer|2013|39